Clinical Trial Update: Examining the Function of Cs4 on Post-COVID-19 Disorders [NA]

View source ↗

Summary

A trial evaluating Cs4 for post-COVID-19 disorders related to long COVID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Cs4

Snippet

Sponsor: The University of Hong Kong | Conditions: Long COVID | NA | Status: COMPLETED